中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

低剂量阿德福韦酯致范可尼综合征合并低磷性骨软化症1例报告

王守庆 赵娜 辛桂杰

王守庆, 赵娜, 辛桂杰. 低剂量阿德福韦酯致范可尼综合征合并低磷性骨软化症1例报告[J]. 临床肝胆病杂志, 2016, 32(1): 159-160. DOI: 10.3969/j.issn.1001-5256.2016.01.033
引用本文: 王守庆, 赵娜, 辛桂杰. 低剂量阿德福韦酯致范可尼综合征合并低磷性骨软化症1例报告[J]. 临床肝胆病杂志, 2016, 32(1): 159-160. DOI: 10.3969/j.issn.1001-5256.2016.01.033
Wang ShouQing, Zhao Na, Xin GuiJie. Fanconi syndrome with hypophosphatemic osteomalacia induced by low-dose adefovir dipivoxil[J]. J Clin Hepatol, 2016, 32(1): 159-160. DOI: 10.3969/j.issn.1001-5256.2016.01.033
Citation: Wang ShouQing, Zhao Na, Xin GuiJie. Fanconi syndrome with hypophosphatemic osteomalacia induced by low-dose adefovir dipivoxil[J]. J Clin Hepatol, 2016, 32(1): 159-160. DOI: 10.3969/j.issn.1001-5256.2016.01.033

低剂量阿德福韦酯致范可尼综合征合并低磷性骨软化症1例报告

DOI: 10.3969/j.issn.1001-5256.2016.01.033
详细信息
  • 中图分类号: R595.3

Fanconi syndrome with hypophosphatemic osteomalacia induced by low-dose adefovir dipivoxil

  • 摘要: <正>阿德福韦酯(ADV)是一种口服单磷酸腺苷核苷酸类药物[1],2002年9月在美国被批准用于治疗慢性乙型肝炎(CHB),2005年4月在中国上市。既往认为小剂量ADV无明显肾毒性[2];近年来,有关长期低剂量使用ADV(10 mg/d)导致肾损伤的报道不断增加。本院收治因服用ADV(10 mg/d)80个月,导致范可尼综合征合并低磷性骨软化症患者1例,现

     

  • [1]WANG JB,KANG HY,CAO XG,et al.The effect of LAM or ADV add-on therapy for HBeA g negative chronic hepatitis B patients with suboptimal response to PEG-IFN[J].Int J Virol,2015,22(5):310-314.(in Chinese)王建彬,康海燕,曹雪改,等.聚乙二醇干扰素应答不佳HBeA g阴性慢性乙肝患者加用拉米夫定或阿德福韦酯疗效观察[J].国际病毒学杂志,2015,22(5):310-314.
    [2]IZZEDINE H,HULOT JS,LAUNAY-VACHER V,et al.Renal safety of adefovir dipivoxil in patients with chronic hepatitis B:two double-blind,randomized,placebo-controlled studies[J].Kidney Int,2004,66(3):1153-1158.
    [3]MAO YM,ZENG MD.Adefovir dipivoxil——a new drug for hepatitis B[J].Chin J Hepatol,2004,12(1):61-63.(in Chinese)茅益民,曾民德.抗乙型病毒性肝炎新药——阿德福韦酯[J].中华肝胆病杂志,2004,12(1):61-63.
    [4]GARA N,ZHAO X,COLLINS MT,et al.Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B[J].Aliment Pharmacol Ther,2012,35(11):1317-1325.
    [5]WANG BF,WANG Y,WANG BY,et al.Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil[J].J Clin Pharm Ther,2015,40(3):345-348.
    [6]SHIMIZU M,FURUSYO N,IKEZAKI H,et al.Predictors of kidney tubular dysfunction induced by adefovir treatment for chronic hepatitis B[J].World J Gastroenterol,2015,21(7):2116-2123.
    [7]WANG XB,ZHU XC,HUANG XY,et al.Fanconi syndrome due to prolonged use of low-dose adefovir[J].J Res Med Sci,2015,20(4):416-419.
    [8]JEONG HJ,LEE JM,LEE TH,et al.Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis b and literature review[J].J Bone Metab,2014,21(1):76-83.
    [9]TANAKA M,SETOGUCHI T,ISHIDOU Y,et al.Pathological femoral fractures due to osteomalacia associated with adefovir dipivoxil treatment for hepatitis B:a case report[J].Diagn Pathol,2012,7:108.
    [10]JIA HY,DING F,CHEN JY,et al.Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B[J].World J Gastroenterol,2015,21(12):3657-3662.
  • 加载中
计量
  • 文章访问数:  1914
  • HTML全文浏览量:  5
  • PDF下载量:  386
  • 被引次数: 0
出版历程
  • 刊出日期:  2016-01-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回